Year To Quarter End Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7357403

Concept 2023-10-01 to
2023-12-31
2022-10-01 to
2022-12-31
Year to quarter end statement of income
Statement of income
Net sales
10,746,000,000 JPY
9,996,000,000 JPY
Cost of sales
7,193,000,000 JPY
5,962,000,000 JPY
Gross profit (loss)
3,552,000,000 JPY
4,034,000,000 JPY
Selling, general and administrative expenses
3,692,000,000 JPY
2,843,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-140,000,000 JPY
1,190,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
0 JPY
Non-operating income
93,000,000 JPY
434,000,000 JPY
Non-operating expenses
Interest expenses
40,000,000 JPY
24,000,000 JPY
Non-operating expenses
49,000,000 JPY
45,000,000 JPY
Ordinary profit (loss)
-96,000,000 JPY
1,579,000,000 JPY
Extraordinary income
Extraordinary income
3,953,000,000 JPY
JPY
Profit (loss) before income taxes
3,856,000,000 JPY
1,579,000,000 JPY
Income taxes - current
1,272,000,000 JPY
159,000,000 JPY
Income taxes - deferred
-156,000,000 JPY
305,000,000 JPY
Income taxes
1,116,000,000 JPY
464,000,000 JPY
Profit (loss)
2,739,000,000 JPY
1,114,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.